You are on page 1of 3

Técnica Analitos Condiciones extracción óptimas Observaciones Separación/Identificación Ref.

HPLC- eupatin, casticin, Hojas secas, molidas (10 g) + 100 ↑ flavonoids totales: Columna: Purospher®Star RP-18, 250 × 4,6 mm, 5 μm 1
API ESI chrysoplenetin, cirsilineol ml disolvente [éter petróleo, n- EtOH, acetone A: water pH 3.2 FA, B: ACN, C: MeOH.
hexano, DCM, acetona, MeOH, ↑ eupatin: EtOH; ↑ Oven T: 26°C
EtOH (96, 80, 60%), agua 85-90ºC] casticin: acetona Gas T: 350°C, flow rate: 10 L/min, nebuliser P: 30 psi, Q T
for 72 h; maceración 72 h 30°C, Capillary V: 3500 V, FS: m/z 100-800, mode: positive
Concentración ion; Scan time: 1 s
HPLC- casticin, eupatin, Hojas (100 g) +1 l DCM; maceración Casticin: [M + H]+ 375 Columna: AscentisExpress C18, 150 × 4,6 mm, 2,7 μm 2
APCI artemetin, 72 h oscuridad Eupatin: [M + H]+ 361
Vol iny: 2 μL,
chrysosplenetin, Sequedad 40ºC, P reducida
A: water 0,1% FA, B: A) and ACN 0,1% FA; isocrático 45%B
chrysosplenol-D, cirsilineol Redisolución ACN
Flow-rate:1.0 mL/min
Mode: positive
APCI conditions: m/z 100–700, interval 0.5 s, scanspeed
1500 amu/s, N2 flow 4.0 L/min, Interface T 350ºC, heatblock
T 300 ºC, DL T 300 ºC, DL V -34 V, probe V +4.5 kV, Q-array
V 1.0 V, detection gain 1.05 kV
HPLC- artemisinin Hojas secas (500 mg) + 13 ml agua Artemisinin (MW 282): Columna: Gemini C18, 250 mm x 4.60 mm, 5 μm 3
ESI- Otros flavonoides hirviendo, 1, 24, 48 h MS1 [M+Na]+ 305 A: H2O FA 0.1%, pH 4 NaOH, B, ACN FA 0.1%; 12% B in A to
MS/MS (identificación) Liofilización MS3 [M+NaCO]+ 277,0 25% B at 60 min, 60% B at 80 min and 100% B at 85 min
Redisolución MeOH:agua (9:1) (30%), [M+Na-CH2CO]+ Flow rate 10 l/min
263,0 (100%), [M+Na- Modo: positive and negative
CO-H20]+ 259,1 (27%) Capillary V 4000 V, nebulizer gas (N2) 15 psi, drying gas (N2)
350ºC 5 l/min. FS: 100–2200 scan time 13,000 m/z/s
HPLC- (+)-catechin, (-)- Hojas secas (0,3 g) + 3 ml MeOH, Columna: 100 RP-18, 25cm x 4mm, 5m 4
DAD epicatechin, quercetin, agitador rotatorio, 24 h Fase móvil: MeOH 5% FA; gradiente lineal 15% a 35% en 15
myricetin, kaempferol, p- Centrifugación 1600 g, 10 min min; e isocrático hasta 20 min
coumaric conjugates, Fllow rate: 1mL/min
caffeic or ferulic Volumen inyección: 20L
conjugates, chlorogenic,
sinapic, cinnamic, gallic
acid, bezoic acid, gentisic
acid, p-anisic acid
HPLC- Compuestos fenólicos Hojas secas (50 g) +500 ml - Phenomenex Gemini C18 column, 250 mm x 3.0 mm, 5 m 5
DAD- (identificación) disolvente (acetone, MeOH) Volumen inyección: 10 L
ESI/MSn maceración 24 h A: ACN 0,1% FA, B: agua 0,1/ FA; 20% A (0 min), 25% A (10
Sequedad 40ºC, P reducida min), 25% A (20 min), 50% A (40 min), 100% A (42–47 min),
Redisolución ACN:agua (20:80), 5 20% A (49–55 min); flow rate 0.4 mL/min
mg residuo/ml T columna: 30ºC
Ion trap MS-ESI, modo negativo, m/z 100–1000, scan speed
13,000 Da/s
Drying gas (N2) flow 10.0 mL/min, nebulizing gas (N2) P 50
psi; nebulizer T 365ºC, capillary potential +400 V, collision
gas (He) P 1 · 10-5 mbar, collision energy 40 V
MSn analysis: auto MSn mode, isolation width 4.0 m/z, 10-
1000 m/z, fragmentation amplitude 1.0 V (MSn up to MS4)
and two precursor ions.
LC-DAD- Compuestos fenólicos Hojas (1 g) + 100 ml MeOH, US 40 Columna Zorbax XDB-C18 5 m, 4.6mmx250 mm 6
ESI-MSn (identificación) min Volumen inyección: 10 l
A: ACN, B: water–0,3% acetic acid; 12–20% A at 0–10 min,
hold for 5 min, linearly gradient to 46% A in 30 min, then
linearly gradient to 80% A at 60 min; flow rate 0.8 mL/min
T columna: 25ºC
Ion trap MS-ESI, modo negativo, FS m/z 100–1000
He collision gas; N2 nebulizing gas
Ion spray V 4.5 kV; sheath gas 55 arbitrary units; auxiliary
gas 5U; capillary T, 350ºC; capillary V-4V; tuve lens offset
voltage -40V
Isolation width precursor ions 3.0 U
(1) Tasdemir D, Tierney M, Sen R, Bergonzi MC, Demirci B, Bilia AR, Baser KHC, Brun R, Chatterjee M. (2015). Antiprotozoal effect of Artemisia indica extracts and essential
oil. Planta Med, 81, 1029–1037
(2) Costa R, Ragusa S, Russo M, Certo G, Franchina FA, Zanotto A, Grasso E, Mondello L, Germanò MP. (2016). Phytochemical screening of Artemisia arborescens L. by means
of advanced chromatographic techniques for identification of health-promoting compounds. Journal of Pharmaceutical and Biomedical Analysis, 117, 499–509
(3) Carbonara T, Pascale R, Argentieri MP, Papadia P, Fanizzi FP, Villanova L, Avato P. (2012). Phytochemical analysis of a herbal tea from Artemisia annua L. J Pharmaceutical
Biomedical Analysis, 62, 79– 86
(4) Carvalho IS, Cavaco T, Brodelius M. (2011). Phenolic composition and antioxidant capacity of six artemisia species. Industrial Crops and Products, 33, 382–388
(5) Gouveia SC, Castilho PC. (2013). Artemisia annua L.: Essential oil and acetone extract composition and antioxidant capacity. Industrial Crops and Products 45, 170– 181
(6) Han J, Ye M, Qiao X, Xu M, Wang BR, Guo DA. (2008). Characterization of phenolic compounds in the Chinese herbal drug Artemisia annua by liquid chromatography
coupled to electrospray ionization mass spectrometry. J Pharmaceutical Biomedical Analysis, 47, 516–525

You might also like